Jane A O'Halloran Selected Research

Jane A O'Halloran Research Topics

Disease

26	COVID-19 02/2024 - 01/2020
6	Infections 01/2023 - 10/2011
4	Human Influenza (Influenza) 12/2021 - 12/2020
3	Inflammation (Inflammations) 02/2021 - 07/2020
3	Myocardial Infarction 01/2020 - 10/2011
2	Pneumonia (Pneumonitis) 01/2023 - 09/2022
2	Diabetes Mellitus 12/2022 - 05/2021
2	Primary Immunodeficiency Diseases 01/2022 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 02/2021 - 01/2021
2	HIV Infections (HIV Infection) 01/2018 - 02/2013
1	Hepatitis 01/2023
1	Obesity 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Amyloidosis 01/2023
1	Weight Gain 12/2022
1	Lymphadenopathy 11/2022
1	Coinfection 09/2022
1	Immunologic Deficiency Syndromes 01/2022
1	Hyperglycemia 05/2021
1	Ketosis 05/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2021
1	Critical Illness (Critically Ill) 02/2021
1	Thrombophilia 02/2021
1	Viremia 02/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Tetanus 12/2020
1	Cytokine Release Syndrome 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Reinfection 01/2020
1	Ischemic Stroke 01/2020
1	Stroke (Strokes) 01/2020
1	Meningitis 01/2017

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2023 - 12/2020
4	AntibodiesIBA 03/2021 - 12/2020
3	Immunologic Factors (Immunomodulators)IBA 01/2023 - 09/2022
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2022
3	Indicators and Reagents (Reagents)IBA 02/2021 - 07/2020
2	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 01/2022
2	Infliximab (Remicade)FDA Link 01/2023 - 09/2022
2	Abatacept (Orencia)FDA Link 01/2023 - 09/2022
2	IntegrasesIBA 12/2022 - 01/2020
2	Chemokine ReceptorsIBA 11/2022 - 03/2022
2	Interferon Type IIBA 11/2022 - 03/2022
2	mRNA VaccinesIBA 11/2022 - 01/2022
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2022 - 01/2022
2	Chloroquine (Aralen)FDA LinkGeneric 08/2022 - 01/2022
2	VaccinesIBA 12/2021 - 03/2021
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 12/2020
2	AntigensIBA 01/2021 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2020
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 07/2020
2	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
2	abacavir (Ziagen)FDA Link 01/2018 - 10/2011
1	cenicrivirocIBA 01/2023
1	InterleukinsIBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	AerosolsIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	dolutegravirIBA 01/2023
1	elvitegravirIBA 01/2023
1	Chemotactic FactorsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	16S Ribosomal RNAIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021
1	bictegravirIBA 05/2021
1	Glycoproteins (Glycoprotein)IBA 03/2021
1	von Willebrand FactorIBA 02/2021
1	ThrombomodulinIBA 02/2021
1	RNA (Ribonucleic Acid)IBA 02/2021
1	leronlimabIBA 02/2021
1	CCR5 Receptors (CCR5 Receptor)IBA 02/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Protein SIBA 01/2021
1	Chemokine CCL5IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 12/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2020
1	InterferonsIBA 12/2020
1	Viral RNAIBA 01/2020
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	NucleosidesIBA 01/2018
1	CollagenIBA 01/2018
1	Reverse Transcriptase InhibitorsIBA 01/2018
1	HDL CholesterolIBA 02/2013
1	CholesterolIBA 02/2013

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2018
3	Artificial Respiration (Mechanical Ventilation) 02/2021 - 01/2021
2	Art Therapy 01/2023 - 01/2020
1	Aftercare (After-Treatment) 02/2021
1	Percutaneous Coronary Intervention 01/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020
1	Kidney Transplantation 01/2017